BENITEC BIOPHARMA INC. (BNTC) Financial Statements
BENITEC BIOPHARMA INC. (BNTC) files with the U.S. Securities and Exchange Commission under CIK 0001808898. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2026
- Net Income
- -$45.55 million
- Total Assets
- $182.62 million
- Net Cash from Operations
- -$16.52 million
Fiscal year ended Jun 30, 2026. Latest periodic SEC filing: Sep 14, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for BNTC in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History